Harvard Bioscience (HBIO) Competitors $2.16 +0.11 (+5.37%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends HBIO vs. AXDX, BNGO, FLDM, QTRX, TMO, A, MTD, ILMN, WAT, and TECHShould you be buying Harvard Bioscience stock or one of its competitors? The main competitors of Harvard Bioscience include Accelerate Diagnostics (AXDX), Bionano Genomics (BNGO), Fluidigm (FLDM), Quanterix (QTRX), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), and Bio-Techne (TECH). Harvard Bioscience vs. Accelerate Diagnostics Bionano Genomics Fluidigm Quanterix Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Illumina Waters Bio-Techne Accelerate Diagnostics (NASDAQ:AXDX) and Harvard Bioscience (NASDAQ:HBIO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership, profitability and earnings. Does the media refer more to AXDX or HBIO? In the previous week, Accelerate Diagnostics had 3 more articles in the media than Harvard Bioscience. MarketBeat recorded 4 mentions for Accelerate Diagnostics and 1 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 1.94 beat Accelerate Diagnostics' score of -0.60 indicating that Harvard Bioscience is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accelerate Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Harvard Bioscience 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has stronger earnings & valuation, AXDX or HBIO? Harvard Bioscience has higher revenue and earnings than Accelerate Diagnostics. Harvard Bioscience is trading at a lower price-to-earnings ratio than Accelerate Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccelerate Diagnostics$11.91M3.58-$61.62M-$2.86-0.59Harvard Bioscience$112.25M0.84-$3.41M-$0.33-6.55 Is AXDX or HBIO more profitable? Harvard Bioscience has a net margin of -14.57% compared to Accelerate Diagnostics' net margin of -471.83%. Accelerate Diagnostics' return on equity of 0.00% beat Harvard Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Accelerate Diagnostics-471.83% N/A -191.66% Harvard Bioscience -14.57%-4.64%-2.40% Which has more risk and volatility, AXDX or HBIO? Accelerate Diagnostics has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, Harvard Bioscience has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Do analysts recommend AXDX or HBIO? Accelerate Diagnostics currently has a consensus target price of $1.00, suggesting a potential downside of 41.18%. Given Accelerate Diagnostics' stronger consensus rating and higher possible upside, research analysts plainly believe Accelerate Diagnostics is more favorable than Harvard Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accelerate Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Harvard Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in AXDX or HBIO? 17.1% of Accelerate Diagnostics shares are held by institutional investors. Comparatively, 80.9% of Harvard Bioscience shares are held by institutional investors. 43.6% of Accelerate Diagnostics shares are held by insiders. Comparatively, 9.0% of Harvard Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in AXDX or HBIO? Harvard Bioscience received 14 more outperform votes than Accelerate Diagnostics when rated by MarketBeat users. Likewise, 72.02% of users gave Harvard Bioscience an outperform vote while only 60.72% of users gave Accelerate Diagnostics an outperform vote. CompanyUnderperformOutperformAccelerate DiagnosticsOutperform Votes35460.72% Underperform Votes22939.28% Harvard BioscienceOutperform Votes36872.02% Underperform Votes14327.98% SummaryHarvard Bioscience beats Accelerate Diagnostics on 10 of the 18 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Harvard Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBIO vs. The Competition Export to ExcelMetricHarvard BioscienceAnalytical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$89.41M$5.08B$23.95B$8.87BDividend YieldN/A0.46%2.76%4.06%P/E Ratio-6.5510.74230.0714.18Price / Sales0.843.903,397.6589.42Price / Cash8.9740.5932.7532.79Price / Book1.442.407.045.12Net Income-$3.41M$515,312.50$659.54M$225.99M7 Day Performance-5.68%-5.56%0.19%-1.32%1 Month Performance-8.86%-8.12%0.77%0.60%1 Year Performance-48.82%-17.04%18.75%26.23% Harvard Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBIOHarvard Bioscience1.566 of 5 stars$2.16+5.4%N/A-48.8%$89.41M$112.25M-6.55490Positive NewsAXDXAccelerate Diagnostics2.4476 of 5 stars$1.70-2.9%$1.00-41.2%-67.0%$43.83M$11.91M-0.59134BNGOBionano Genomics1.3717 of 5 stars$0.21-8.7%$1.50+616.3%-85.7%$21.36M$36.12M-0.09300Gap UpHigh Trading VolumeFLDMFluidigmN/AN/AN/AN/A$283.76M$130.58M-4.76615QTRXQuanterix2.4262 of 5 stars$11.02-0.4%$23.25+111.0%-52.5%$424.47M$122.37M0.00460TMOThermo Fisher Scientific4.9906 of 5 stars$512.86+0.7%$649.33+26.6%+9.3%$194.74B$42.86B32.15122,000Buyback AnnouncementPositive NewsAAgilent Technologies4.3995 of 5 stars$128.57+2.3%$144.36+12.3%+12.8%$36.94B$6.83B26.6718,100Upcoming EarningsNews CoveragePositive NewsMTDMettler-Toledo International4.1104 of 5 stars$1,166.90+0.5%$1,338.75+14.7%+11.1%$24.49B$3.79B31.4617,300Positive NewsILMNIllumina4.418 of 5 stars$131.68-2.5%$164.00+24.5%+34.9%$21.41B$4.50B0.009,300Positive NewsWATWaters4.1245 of 5 stars$357.69+3.8%$365.85+2.3%+37.0%$20.47B$2.96B34.137,900TECHBio-Techne4.8558 of 5 stars$68.72+3.5%$81.78+19.0%+8.1%$10.55B$1.16B73.113,100 Related Companies and Tools Related Companies AXDX Competitors BNGO Competitors FLDM Competitors QTRX Competitors TMO Competitors A Competitors MTD Competitors ILMN Competitors WAT Competitors TECH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HBIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
